Previous Close | 15.82 |
Open | 16.71 |
Bid | 16.32 x 200 |
Ask | 16.39 x 100 |
Day's Range | 16.21 - 16.84 |
52 Week Range | 14.88 - 29.51 |
Volume | |
Avg. Volume | 464,414 |
Market Cap | 672.226M |
Beta (5Y Monthly) | 1.21 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.13 |
Earnings Date | Apr 29, 2024 - May 03, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 26.67 |
SANTA CLARA, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming Barclays 26th Annual Global Healthcare Conference in Miami. Management will be hosting a fireside chat on Tuesday, March 12, at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Investors interested in listening to the conference call may do so
With the business potentially at an important milestone, we thought we'd take a closer look at SI-BONE, Inc.'s...